0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia
Status:
Enrolling by invitation
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Chlorhexidine is a effective strategy in reducing ventilator associated pneumonia. However,
it is unclear if prophylactic 0.12% chlorhexidine oral rinse can reduce the risk of
non-ventilator hospital-acquired pneumonia among hospitalized patients.